Annemarie Hekman

Suggest Changes
Learn More
Seven patients with low-grade non-Hodgkin's lymphoma were treated with a combination of a murine monoclonal antibody directed against the B-cell-specific antigen CD19 (CLB-CD10), given twice weekly,(More)
  • 1